ArticleCancer medicine2022

Development and external validation of a nomogram for individualized adjuvant imatinib duration for high-risk gastrointestinal stromal tumors: A multicenter retrospective cohort study.

Ruolin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.